Work

Phase 1 study of CART-ddBCMA in relapsed or refractory multiple myeloma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.8003

Authors: Matthew J. Frigault, Jacalyn Rosenblatt, Daniella Cook, Ha Na Cho, Gabriel D. Depinho, Emma Logan, Jessica Liegel, Yougeesh Prabhakar, Christine Cornwell, Kamalika Banerjee, Anand Rotte, Christopher Ryan Heery, David Avigan, Andrzej J. Jakubowiak, Michael Russell Bishop

Institutions: Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Harvard University, University of Chicago, Precision BioSciences (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281607040

Cites:

Cited by: 7

Related to: 10